The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type Single-ingredient Codeine Multi-ingredient Medications Segment by Application Narcotic Analgesic Antitussive Others By Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Colombia Middle East & Africa Turkey Saudi Arabia UAE By Company Taiji Mallinckrodt TEVA Johnson & Johnson Medreich Sanofi Aventis Cipla Hikma Pharmaceutical Associates Novartis Apotex Mylan Aristo Pharma GmbH Lannett Company Laboratoire Riva
1 Codeine Narcotic Market Overview 1.1 Product Overview and Scope of Codeine Narcotic 1.2 Codeine Narcotic Segment by Type 1.2.1 Global Codeine Narcotic Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Single-ingredient Codeine 1.2.3 Multi-ingredient Medications 1.3 Codeine Narcotic Segment by Application 1.3.1 Global Codeine Narcotic Sales Comparison by Application: (2022-2028) 1.3.2 Narcotic Analgesic 1.3.3 Antitussive 1.3.4 Others 1.4 Global Codeine Narcotic Market Size Estimates and Forecasts 1.4.1 Global Codeine Narcotic Revenue 2017-2028 1.4.2 Global Codeine Narcotic Sales 2017-2028 1.4.3 Codeine Narcotic Market Size by Region: 2017 Versus 2021 Versus 2028 2 Codeine Narcotic Market Competition by Manufacturers 2.1 Global Codeine Narcotic Sales Market Share by Manufacturers (2017-2022) 2.2 Global Codeine Narcotic Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Codeine Narcotic Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Codeine Narcotic Manufacturing Sites, Area Served, Product Type 2.5 Codeine Narcotic Market Competitive Situation and Trends 2.5.1 Codeine Narcotic Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Codeine Narcotic Players Market Share by Revenue 2.5.3 Global Codeine Narcotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Codeine Narcotic Retrospective Market Scenario by Region 3.1 Global Codeine Narcotic Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Codeine Narcotic Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Codeine Narcotic Market Facts & Figures by Country 3.3.1 North America Codeine Narcotic Sales by Country 3.3.2 North America Codeine Narcotic Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Codeine Narcotic Market Facts & Figures by Country 3.4.1 Europe Codeine Narcotic Sales by Country 3.4.2 Europe Codeine Narcotic Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Codeine Narcotic Market Facts & Figures by Region 3.5.1 Asia Pacific Codeine Narcotic Sales by Region 3.5.2 Asia Pacific Codeine Narcotic Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Codeine Narcotic Market Facts & Figures by Country 3.6.1 Latin America Codeine Narcotic Sales by Country 3.6.2 Latin America Codeine Narcotic Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.6.6 Colombia 3.7 Middle East and Africa Codeine Narcotic Market Facts & Figures by Country 3.7.1 Middle East and Africa Codeine Narcotic Sales by Country 3.7.2 Middle East and Africa Codeine Narcotic Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Codeine Narcotic Historic Market Analysis by Type 4.1 Global Codeine Narcotic Sales Market Share by Type (2017-2022) 4.2 Global Codeine Narcotic Revenue Market Share by Type (2017-2022) 4.3 Global Codeine Narcotic Price by Type (2017-2022) 5 Global Codeine Narcotic Historic Market Analysis by Application 5.1 Global Codeine Narcotic Sales Market Share by Application (2017-2022) 5.2 Global Codeine Narcotic Revenue Market Share by Application (2017-2022) 5.3 Global Codeine Narcotic Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Taiji 6.1.1 Taiji Corporation Information 6.1.2 Taiji Description and Business Overview 6.1.3 Taiji Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Taiji Codeine Narcotic Product Portfolio 6.1.5 Taiji Recent Developments/Updates 6.2 Mallinckrodt 6.2.1 Mallinckrodt Corporation Information 6.2.2 Mallinckrodt Description and Business Overview 6.2.3 Mallinckrodt Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Mallinckrodt Codeine Narcotic Product Portfolio 6.2.5 Mallinckrodt Recent Developments/Updates 6.3 TEVA 6.3.1 TEVA Corporation Information 6.3.2 TEVA Description and Business Overview 6.3.3 TEVA Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.3.4 TEVA Codeine Narcotic Product Portfolio 6.3.5 TEVA Recent Developments/Updates 6.4 Johnson & Johnson 6.4.1 Johnson & Johnson Corporation Information 6.4.2 Johnson & Johnson Description and Business Overview 6.4.3 Johnson & Johnson Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Johnson & Johnson Codeine Narcotic Product Portfolio 6.4.5 Johnson & Johnson Recent Developments/Updates 6.5 Medreich 6.5.1 Medreich Corporation Information 6.5.2 Medreich Description and Business Overview 6.5.3 Medreich Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Medreich Codeine Narcotic Product Portfolio 6.5.5 Medreich Recent Developments/Updates 6.6 Sanofi Aventis 6.6.1 Sanofi Aventis Corporation Information 6.6.2 Sanofi Aventis Description and Business Overview 6.6.3 Sanofi Aventis Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Sanofi Aventis Codeine Narcotic Product Portfolio 6.6.5 Sanofi Aventis Recent Developments/Updates 6.7 Cipla 6.6.1 Cipla Corporation Information 6.6.2 Cipla Description and Business Overview 6.6.3 Cipla Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Cipla Codeine Narcotic Product Portfolio 6.7.5 Cipla Recent Developments/Updates 6.8 Hikma 6.8.1 Hikma Corporation Information 6.8.2 Hikma Description and Business Overview 6.8.3 Hikma Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Hikma Codeine Narcotic Product Portfolio 6.8.5 Hikma Recent Developments/Updates 6.9 Pharmaceutical Associates 6.9.1 Pharmaceutical Associates Corporation Information 6.9.2 Pharmaceutical Associates Description and Business Overview 6.9.3 Pharmaceutical Associates Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Pharmaceutical Associates Codeine Narcotic Product Portfolio 6.9.5 Pharmaceutical Associates Recent Developments/Updates 6.10 Novartis 6.10.1 Novartis Corporation Information 6.10.2 Novartis Description and Business Overview 6.10.3 Novartis Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Novartis Codeine Narcotic Product Portfolio 6.10.5 Novartis Recent Developments/Updates 6.11 Apotex 6.11.1 Apotex Corporation Information 6.11.2 Apotex Codeine Narcotic Description and Business Overview 6.11.3 Apotex Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Apotex Codeine Narcotic Product Portfolio 6.11.5 Apotex Recent Developments/Updates 6.12 Mylan 6.12.1 Mylan Corporation Information 6.12.2 Mylan Codeine Narcotic Description and Business Overview 6.12.3 Mylan Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Mylan Codeine Narcotic Product Portfolio 6.12.5 Mylan Recent Developments/Updates 6.13 Aristo Pharma GmbH 6.13.1 Aristo Pharma GmbH Corporation Information 6.13.2 Aristo Pharma GmbH Codeine Narcotic Description and Business Overview 6.13.3 Aristo Pharma GmbH Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.13.4 Aristo Pharma GmbH Codeine Narcotic Product Portfolio 6.13.5 Aristo Pharma GmbH Recent Developments/Updates 6.14 Lannett Company 6.14.1 Lannett Company Corporation Information 6.14.2 Lannett Company Codeine Narcotic Description and Business Overview 6.14.3 Lannett Company Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.14.4 Lannett Company Codeine Narcotic Product Portfolio 6.14.5 Lannett Company Recent Developments/Updates 6.15 Laboratoire Riva 6.15.1 Laboratoire Riva Corporation Information 6.15.2 Laboratoire Riva Codeine Narcotic Description and Business Overview 6.15.3 Laboratoire Riva Codeine Narcotic Sales, Revenue and Gross Margin (2017-2022) 6.15.4 Laboratoire Riva Codeine Narcotic Product Portfolio 6.15.5 Laboratoire Riva Recent Developments/Updates 7 Codeine Narcotic Manufacturing Cost Analysis 7.1 Codeine Narcotic Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Codeine Narcotic 7.4 Codeine Narcotic Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Codeine Narcotic Distributors List 8.3 Codeine Narcotic Customers 9 Codeine Narcotic Market Dynamics 9.1 Codeine Narcotic Industry Trends 9.2 Codeine Narcotic Market Drivers 9.3 Codeine Narcotic Market Challenges 9.4 Codeine Narcotic Market Restraints 10 Global Market Forecast 10.1 Codeine Narcotic Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Codeine Narcotic by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Codeine Narcotic by Type (2023-2028) 10.2 Codeine Narcotic Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Codeine Narcotic by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Codeine Narcotic by Application (2023-2028) 10.3 Codeine Narcotic Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Codeine Narcotic by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Codeine Narcotic by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer
List of Tables Table 1. Global Codeine Narcotic Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million) Table 2. Global Codeine Narcotic Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million) Table 3. Global Codeine Narcotic Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Codeine Narcotic Market Competitive Situation by Manufacturers in 2021 Table 5. Global Codeine Narcotic Sales (Units) of Key Manufacturers (2017-2022) Table 6. Global Codeine Narcotic Sales Market Share by Manufacturers (2017-2022) Table 7. Global Codeine Narcotic Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Codeine Narcotic Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Codeine Narcotic Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Codeine Narcotic Manufacturing Sites and Area Served Table 11. Manufacturers Codeine Narcotic Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Codeine Narcotic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Codeine Narcotic as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Codeine Narcotic Sales by Region (2017-2022) & (Units) Table 16. Global Codeine Narcotic Sales Market Share by Region (2017-2022) Table 17. Global Codeine Narcotic Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Codeine Narcotic Revenue Market Share by Region (2017-2022) Table 19. North America Codeine Narcotic Sales by Country (2017-2022) & (Units) Table 20. North America Codeine Narcotic Sales Market Share by Country (2017-2022) Table 21. North America Codeine Narcotic Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Codeine Narcotic Revenue Market Share by Country (2017-2022) Table 23. Europe Codeine Narcotic Sales by Country (2017-2022) & (Units) Table 24. Europe Codeine Narcotic Sales Market Share by Country (2017-2022) Table 25. Europe Codeine Narcotic Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Codeine Narcotic Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Codeine Narcotic Sales by Region (2017-2022) & (Units) Table 28. Asia Pacific Codeine Narcotic Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Codeine Narcotic Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Codeine Narcotic Revenue Market Share by Region (2017-2022) Table 31. Latin America Codeine Narcotic Sales by Country (2017-2022) & (Units) Table 32. Latin America Codeine Narcotic Sales Market Share by Country (2017-2022) Table 33. Latin America Codeine Narcotic Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Codeine Narcotic Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Codeine Narcotic Sales by Country (2017-2022) & (Units) Table 36. Middle East and Africa Codeine Narcotic Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Codeine Narcotic Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Codeine Narcotic Revenue Market Share by Country (2017-2022) Table 39. Global Codeine Narcotic Sales by Type (2017-2022) & (Units) Table 40. Global Codeine Narcotic Sales Market Share by Type (2017-2022) Table 41. Global Codeine Narcotic Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Codeine Narcotic Revenue Share by Type (2017-2022) Table 43. Global Codeine Narcotic Price by Type (2017-2022) & (US$/Unit) Table 44. Global Codeine Narcotic Sales (Units) by Application (2017-2022) Table 45. Global Codeine Narcotic Sales Market Share by Application (2017-2022) Table 46. Global Codeine Narcotic Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Codeine Narcotic Revenue Share by Application (2017-2022) Table 48. Global Codeine Narcotic Price by Application (2017-2022) & (US$/Unit) Table 49. Taiji Corporation Information Table 50. Taiji Description and Business Overview Table 51. Taiji Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Taiji Codeine Narcotic Product Table 53. Taiji Recent Developments/Updates Table 54. Mallinckrodt Corporation Information Table 55. Mallinckrodt Description and Business Overview Table 56. Mallinckrodt Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Mallinckrodt Codeine Narcotic Product Table 58. Mallinckrodt Recent Developments/Updates Table 59. TEVA Corporation Information Table 60. TEVA Description and Business Overview Table 61. TEVA Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. TEVA Codeine Narcotic Product Table 63. TEVA Recent Developments/Updates Table 64. Johnson & Johnson Corporation Information Table 65. Johnson & Johnson Description and Business Overview Table 66. Johnson & Johnson Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Johnson & Johnson Codeine Narcotic Product Table 68. Johnson & Johnson Recent Developments/Updates Table 69. Medreich Corporation Information Table 70. Medreich Description and Business Overview Table 71. Medreich Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. Medreich Codeine Narcotic Product Table 73. Medreich Recent Developments/Updates Table 74. Sanofi Aventis Corporation Information Table 75. Sanofi Aventis Description and Business Overview Table 76. Sanofi Aventis Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. Sanofi Aventis Codeine Narcotic Product Table 78. Sanofi Aventis Recent Developments/Updates Table 79. Cipla Corporation Information Table 80. Cipla Description and Business Overview Table 81. Cipla Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. Cipla Codeine Narcotic Product Table 83. Cipla Recent Developments/Updates Table 84. Hikma Corporation Information Table 85. Hikma Description and Business Overview Table 86. Hikma Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 87. Hikma Codeine Narcotic Product Table 88. Hikma Recent Developments/Updates Table 89. Pharmaceutical Associates Corporation Information Table 90. Pharmaceutical Associates Description and Business Overview Table 91. Pharmaceutical Associates Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 92. Pharmaceutical Associates Codeine Narcotic Product Table 93. Pharmaceutical Associates Recent Developments/Updates Table 94. Novartis Corporation Information Table 95. Novartis Description and Business Overview Table 96. Novartis Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 97. Novartis Codeine Narcotic Product Table 98. Novartis Recent Developments/Updates Table 99. Apotex Corporation Information Table 100. Apotex Description and Business Overview Table 101. Apotex Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 102. Apotex Codeine Narcotic Product Table 103. Apotex Recent Developments/Updates Table 104. Mylan Corporation Information Table 105. Mylan Description and Business Overview Table 106. Mylan Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 107. Mylan Codeine Narcotic Product Table 108. Mylan Recent Developments/Updates Table 109. Aristo Pharma GmbH Corporation Information Table 110. Aristo Pharma GmbH Description and Business Overview Table 111. Aristo Pharma GmbH Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 112. Aristo Pharma GmbH Codeine Narcotic Product Table 113. Aristo Pharma GmbH Recent Developments/Updates Table 114. Lannett Company Corporation Information Table 115. Lannett Company Description and Business Overview Table 116. Lannett Company Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 117. Lannett Company Codeine Narcotic Product Table 118. Lannett Company Recent Developments/Updates Table 119. Laboratoire Riva Corporation Information Table 120. Laboratoire Riva Description and Business Overview Table 121. Laboratoire Riva Codeine Narcotic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 122. Laboratoire Riva Codeine Narcotic Product Table 123. Laboratoire Riva Recent Developments/Updates Table 124. Production Base and Market Concentration Rate of Raw Material Table 125. Key Suppliers of Raw Materials Table 126. Codeine Narcotic Distributors List Table 127. Codeine Narcotic Customers List Table 128. Codeine Narcotic Market Trends Table 129. Codeine Narcotic Market Drivers Table 130. Codeine Narcotic Market Challenges Table 131. Codeine Narcotic Market Restraints Table 132. Global Codeine Narcotic Sales Forecast by Type (2023-2028) & (Units) Table 133. Global Codeine Narcotic Sales Market Share Forecast by Type (2023-2028) Table 134. Global Codeine Narcotic Revenue Forecast by Type (2023-2028) & (US$ Million) Table 135. Global Codeine Narcotic Revenue Market Share Forecast by Type (2023-2028) Table 136. Global Codeine Narcotic Sales Forecast by Application (2023-2028) & (Units) Table 137. Global Codeine Narcotic Sales Market Share Forecast by Application (2023-2028) Table 138. Global Codeine Narcotic Revenue Forecast by Application (2023-2028) & (US$ Million) Table 139. Global Codeine Narcotic Revenue Market Share Forecast by Application (2023-2028) Table 140. Global Codeine Narcotic Sales Forecast by Region (2023-2028) & (Units) Table 141. Global Codeine Narcotic Sales Market Share Forecast by Region (2023-2028) Table 142. Global Codeine Narcotic Revenue Forecast by Region (2023-2028) & (US$ Million) Table 143. Global Codeine Narcotic Revenue Market Share Forecast by Region (2023-2028) Table 144. Research Programs/Design for This Report Table 145. Key Data Information from Secondary Sources Table 146. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Codeine Narcotic Figure 2. Global Codeine Narcotic Market Share by Type in 2021 & 2028 Figure 3. Single-ingredient Codeine Product Picture Figure 4. Multi-ingredient Medications Product Picture Figure 5. Global Codeine Narcotic Market Share by Application in 2021 & 2028 Figure 6. Narcotic Analgesic Figure 7. Antitussive Figure 8. Others Figure 9. Global Codeine Narcotic Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Codeine Narcotic Market Size (2017-2028) & (US$ Million) Figure 11. Global Codeine Narcotic Sales (2017-2028) & (Units) Figure 12. Codeine Narcotic Sales Share by Manufacturers in 2021 Figure 13. Global Codeine Narcotic Revenue Share by Manufacturers in 2021 Figure 14. The Global 5 and 10 Largest Codeine Narcotic Players: Market Share by Revenue in 2021 Figure 15. Codeine Narcotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 16. Global Codeine Narcotic Sales Market Share by Region (2017-2022) Figure 17. Global Codeine Narcotic Sales Market Share by Region in 2021 Figure 18. Global Codeine Narcotic Revenue Market Share by Region (2017-2022) Figure 19. Global Codeine Narcotic Revenue Market Share by Region in 2021 Figure 20. United States Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Canada Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Germany Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. France Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. U.K. Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Italy Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Russia Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. China Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Japan Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. South Korea Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. India Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Australia Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. China Taiwan Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Indonesia Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Thailand Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Malaysia Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Mexico Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Brazil Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Argentina Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Colombia Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Turkey Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Saudi Arabia Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. UAE Codeine Narcotic Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Sales Market Share of Codeine Narcotic by Type (2017-2022) Figure 44. Manufacturing Cost Structure of Codeine Narcotic Figure 45. Manufacturing Process Analysis of Codeine Narcotic Figure 46. Codeine Narcotic Industrial Chain Analysis Figure 47. Channels of Distribution Figure 48. Distributors Profiles Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed